C0555176||Bacteriology
C1610733||Urine Specimens
C0025266||Men
C1704272||Benign Prostatic Hyperplasia
C0004659||Bacteriuria
C0042029||urinary tract infections
C0243088||sequelae
C1704272||benign prostatic hyperplasia
C1704272||benign prostatic hyperplasia
C0376554||knowledge
C0042036||urine
C0555176||bacteriology
C0025266||men
C1704272||benign prostatic hyperplasia
C0014406||environment
C0030677||management
C0004659||bacteriuria
C3494793||bacterial isolates
C0430404||cultured urine
C0025266||men
C1704272||benign prostatic hyperplasia
C0033522||prospective study
C0574785||lower urinary tract symptoms
C1704272||benign prostatic hyperplasia
C2603343||studied
C1610733||Urine samples
C0026018||microscopy
C0430400||culture
C0442711||standard protocol
C2603343||studied
C3494793||Bacterial isolates
C1705920||species
C0427941||organisms isolated
C0014834||Escherichia coli
C0427941||organism isolated
C1295805||Providencia species
C3494793||bacterial isolates
C0020933||imipenem
C0066005||meropenem
C0028156||nitrofurantoin
C0007562||cefuroxime
C3854019||gentamicin
C0028902||ofloxacin
C1273937||no significant
C0426731||prostate size
C0004659||bacteriuria
C0004659||Bacteriuria
C0243095||finding
C1704272||benign prostatic hyperplasia
C3494793||bacterial isolates
C0442027||oral
C3536856||cephalosporins
C0949665||fluoroquinolones
C0162791||guidelines
C0003232||antibiotics